Integer Holdings (ITGR) Change in Account Payables (2010 - 2026)
Integer Holdings (ITGR) reported Change in Account Payables of $9.4 million for Q2 2026, down 7.51% on a YoY basis from $10.2 million in Q2 2025, and up 351.53% sequentially from -$3.8 million in Q4 2025.
Integer Holdings (ITGR) Change in Account Payables (2010 - 2026) Analysis & Trends
Integer Holdings (ITGR) has 17 years of Change in Account Payables data on file, last reported at $9.4 million in Q2 2026.
- For the quarter ending Q2 2026, Change in Account Payables fell 7.51% year-over-year to $9.4 million; the trailing twelve-month figure through Apr 2026 stood at -$1.3 million (up 85.32% YoY), and the FY2025 full-year result was -$566000.0, up 96.59% from the prior year.
- Change in Account Payables advanced to $9.4 million in Q2 2026, from -$3.8 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $15.0 million in Q2 2022 to a low of -$20.9 million in Q4 2024.
- A 5-year average of $1.0 million and a median of $514000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables plunged 6092.84% in 2024 and surged 282.43% in 2025, its largest moves.
- Tracing ITGR's Change in Account Payables over 5 years: stood at $514000.0 in 2022, then tumbled by 32.1% to $349000.0 in 2023, then sank by 6092.84% to -$20.9 million in 2024, then soared by 82.06% to -$3.8 million in 2025, then soared by 351.53% to $9.4 million in 2026.
- Business Quant data shows ITGR's Change in Account Payables at $9.4 million in Q2 2026, -$3.8 million in Q4 2025, and -$8.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integer Holdings | 3.34 Bn | 3.33 Bn | 109.60 Mn | 9.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 9.44 Mn |
| Apr 3, 2026 | 9.44 Mn |
| Dec 31, 2025 | -3.75 Mn |
| Dec 31, 2025 | -3.75 Mn |
| Sep 26, 2025 | -8.37 Mn |
| Sep 26, 2025 | -8.37 Mn |
| Jun 27, 2025 | 1.35 Mn |
| Jun 27, 2025 | 1.35 Mn |
| Mar 28, 2025 | 10.21 Mn |
| Mar 28, 2025 | 10.21 Mn |
| Dec 31, 2024 | -20.92 Mn |
| Dec 31, 2024 | -20.92 Mn |
| Sep 27, 2024 | -2.77 Mn |
| Sep 27, 2024 | -2.77 Mn |
| Jun 28, 2024 | 4.40 Mn |
| Jun 28, 2024 | 4.40 Mn |
| Mar 29, 2024 | 2.67 Mn |
| Mar 29, 2024 | 2.67 Mn |
| Dec 31, 2023 | 349,000.00 |
| Dec 31, 2023 | 349,000.00 |